
Chief Brand Officer @MJHLifeSciences focused on innovative, audience-driven results @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more
United States
Joined August 2011
- Tweets3.9K
- Following623
- Followers820
- Likes751
FDA Approves Neladalkib for Locally Advanced or Metastatic ALK+ NSCLC onclive.com/view/fda-approve… #LCSM
33
FDA Approves Bepirovirsen for Chronic Hepatitis B hcplive.com/view/fda-approve…
83
FDA Approves Pirtobrutinib for Previously Untreated CLL/SLL onclive.com/view/fda-approve…
56
Adding DLL3×CD3 bispecific tarlatamab to durvalumab maintenance improved OS, PFS, and ORR versus durvalumab alone after platinum/etoposide/durvalumab induction in ES-SCLC onclive.com/view/durvalumab-…
49
FDA Approves Rusfertide for Polycythemia Vera onclive.com/view/fda-approve…
1
57
FDA Approves Daraxonrasib for Previously Treated Metastatic Pancreatic Cancer cancernetwork.com/view/fda-a…
43
Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma onclive.com/view/intismeran-…
32
After a positive Ad Comm, the FDA has done a 180 and approves RP1/Nivolumab after progression on anti–PD-1 therapy in Melanoma cancernetwork.com/view/fda-a…
83
FDA Approves Orexin Agonist Oveporexton for Narcolepsy Type 1 neurologylive.com/view/fda-a…
65
FDA Accepts NDA for Daraxonrasib in Metastatic Pancreatic Cancer targetedonc.com/view/fda-acc…
1
71
FDA Approves Zidesamtinib in Pretreated ROS1+ NSCLC onclive.com/view/fda-approve… #LCSM
2
93
FDA Approves Enlicitide for LDL-C Lowering in Adults With Hypercholesterolemia hcplive.com/view/fda-approve…
1
56
Soficitinib (ICP-332) Meets Primary Endpoint in Phase 3 Trial for Moderate to Severe AD dermatologytimes.com/view/so…
1
57
FDA Approves Gedatolisib Plus Fulvestrant ± Palbociclib for Hormone Receptor–Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer onclive.com/view/fda-approve…
1
65
FDA Approves At-Home Starting Dose for Lecanemab, Marking First Subcutaneous Initiation Option for Alzheimer Disease Treatment neurologylive.com/view/fda-a…
1
74
FDA Approves Atacicept (Trutakna) for IgA Nephropathy hcplive.com/view/fda-approve…
2
655
Namodenoson Yields Durable Survival Outcomes in Pretreated Pancreatic Cancer cancernetwork.com/view/namod…
29
FDA Approves Capivasertib Plus Abiraterone and Prednisone for PTEN-Deficient mHSPC onclive.com/view/fda-approve…
29
AZ is joining the GLP1 market: Elecoglipron Advances to Phase 3, Shows Phase 2 Weight Loss, Glycemic Data hcplive.com/view/elecoglipro…
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer onclive.com/view/vopimetosta…